1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow arginyllysine: new trials by email Literature Review of arginyllysine trials Research Report on arginyllysine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients arginine/lysine - Gastroenteropancreatic Neuroendocrine Tumors | Phase 4 | Completed | Advanced Accelerator Applications | 42 | 2021-01-25 | 2025-01-24 |
Carcinoid Tumor (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Neuroendocrine Tumors (1)
Advanced Accelerator Applications (1)
Italy (1) · Netherlands (1) · Poland (1) · United Kingdom (1)
2019 (1)